
    
      Prospective, comparative, three arm, short term, non-interventional study with correlative
      biomarker endpoints. Sixty (60) obese (â‰¥ 30 BMI) newly diagnosed ER+ postmenopausal breast
      cancer patients will be recruited to participate in a short term (30 day) Phase 0 biomarker
      evaluation study prior to surgical resection.
    
  